BeOne Medicines Ltd.

ONCReported to SECin USCIK 0001651308Filings at SEC EDGAR

ONC is one of 2 listed share classes under this CIK; the filings below cover all of them.

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 154. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 154
Form 4 lines at BeOne Medicines Ltd., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Wang Xiaodong—Option exercisenothing paid403,364 sharesSep 30, 2026Wang Xiaodongnothing paidExercise · Sep 30Option exercise403,364Sep 30, 2026
Wang Xiaodong—Open-market sell$271,012738 sharesSep 30, 2026Wang Xiaodong$271,012Sell · Sep 30Open-market sell738Sep 30, 2026
Wang Xiaodong—Open-market sell$5,324,55014,525 sharesSep 30, 2026Wang Xiaodong$5,324,550Sell · Sep 30Open-market sell14,525Sep 30, 2026
Wang Xiaodong—Open-market sell$748,8912,047 sharesSep 30, 2026Wang Xiaodong$748,891Sell · Sep 30Open-market sell2,047Sep 30, 2026
Wang Xiaodong—Open-market sell$1,244,7473,419 sharesSep 30, 2026Wang Xiaodong$1,244,747Sell · Sep 30Open-market sell3,419Sep 30, 2026